Beximco Pharmaceuticals PLC. (BST:R2WA)
0.7000
+0.0750 (12.00%)
At close: Nov 20, 2026
| Market Cap | 486.74M +46.4% |
| Revenue (ttm) | 408.51M +11.6% |
| Net Income | 65.70M +20.5% |
| EPS | 0.10 +20.5% |
| Shares Out | n/a |
| PE Ratio | 7.26 |
| Forward PE | 6.71 |
| Dividend | 0.07 (10.13%) |
| Ex-Dividend Date | Nov 18, 2026 |
| Volume | n/a |
| Open | 0.6250 |
| Previous Close | 0.6250 |
| Day's Range | 0.6250 - 0.7000 |
| 52-Week Range | 0.3800 - 0.7900 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Jan 27, 2027 |
